| Identification | Back Directory | [Name]
L-Lysinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl-N-[4-(hydroxymethyl)phenyl]-N6-(triphenylmethyl)- | [CAS]
1116085-98-3 | [Synonyms]
Fmoc-Phe-Lys(Trt)-PAB
L-Lysinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl-N-[4-(hydroxymethyl)phenyl]-N6-(triphenylmethyl)-
L-Lysinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl-N-[4-(hydroxymethyl)phenyl]-N6-(triphenylmethyl)- USP/EP/BP | [Molecular Formula]
C56H54N4O5 | [MDL Number]
MFCD34180563 | [MOL File]
1116085-98-3.mol | [Molecular Weight]
863.05 |
| Hazard Information | Back Directory | [Biological Activity]
Fmoc-Phe-Lys(Trt)-PAB is a cleavable ADC linker that can be used to synthesize antibody drug conjugates (ADCs). | [in vitro]
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. | [target]
|
|
|